Home › Cardiovascular Disease › Michigan › Lansing
Cardiovascular Disease clinical trials in Lansing, MI
3 studies for Cardiovascular Disease are looking for participants at sites in and around Lansing (within about 30 miles). Open a study to see who can join and how to contact the study team.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- UMH-Sparrow Clinical Research Institute, Lansing
Product Surveillance Registry
RecruitingObservational study
- Lansing, Lansing
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Lansing
Cardiovascular Disease trials in other cities
- Boston, MA36 studies
- New York City, NY32 studies
- Washington, DC29 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Philadelphia, PA21 studies
- Chicago, IL21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN19 studies
Other studies in Lansing
- Lung Cancer11 studies
- Prostate Cancer10 studies
- Breast Cancer10 studies
- Non-Small Cell Lung Cancer9 studies
- Cancer (all types)7 studies
- Bladder Cancer5 studies
- Laryngeal Cancer5 studies
- Disorders of Excessive Somnolence5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Endometrial Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.